Pyrethrum Extract

CHEMBL2108766 Phase 4 Onaylandı Unknown
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

Pyrethrum extract is a naturally occurring insecticidal mixture of six pyrethrins derived from Chrysanthemum cinerariaefolium flowers that disrupts insect neuronal sodium channel function, causing repetitive nerve firing, paralysis, and death of insects and ectoparasites. It is used as an insecticide and antiparasitic agent for the treatment of lice infestations and as an environmental pesticide.

Etki Mekanizması

Disrupts essential metabolic pathways or structural components of parasitic organisms, leading to paralysis, starvation, or death of the parasite.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanizma

Disrupts essential metabolic pathways or structural components of parasitic organisms, leading to paralysis, starvation, or death of the parasite.

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

Pyrethrum extract is a naturally occurring insecticidal mixture of six pyrethrins derived from Chrysanthemum cinerariaefolium flowers that disrupts insect neuronal sodium channel function, causing repetitive nerve firing, paralysis, and death of insects and ectoparasites. It is used as an insecticide and antiparasitic agent for the treatment of lice infestations and as an environmental pesticide.

Disrupts essential metabolic pathways or structural components of parasitic organisms, leading to paralysis, starvation, or death of the parasite.

Yes, Pyrethrum Extract is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2108766. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.